Analysen von Amit Roy
| 15.08.12 | Sanofi neutral | Nomura | |
| 15.08.12 | Novartis buy | Nomura | |
| 15.08.12 | GSK neutral | Nomura | |
| 10.08.12 | Merck buy | Nomura | |
| 03.08.12 | Novo Nordisk reduce | Nomura | |
| 02.08.12 | AstraZeneca reduce | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 18.07.12 | Sanofi neutral | Nomura | |
|
Werbung
|
|||
| 18.07.12 | GSK neutral | Nomura | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 13.07.12 | Novartis buy | Nomura | |
| 06.07.12 | Shire buy | Nomura | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 25.06.12 | Shire buy | Nomura | |
| 22.06.12 | Roche neutral | Nomura | |
| 11.06.12 | Roche neutral | Nomura | |
| 23.04.12 | AstraZeneca reduce | Nomura | |
| 23.04.12 | GSK neutral | Nomura | |
| 23.04.12 | Novartis buy | Nomura | |
| 11.04.12 | Roche neutral | Nomura | |
| 05.04.12 | Shire buy | Nomura | |
| 22.03.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 21.02.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 15.02.12 | Actelion neutral | Nomura | |
| 09.02.12 | Sanofi neutral | Nomura | |
| 07.02.12 | Sanofi neutral | Nomura | |
| 03.02.12 | GSK neutral | Nomura | |
| 02.02.12 | Roche neutral | Nomura | |
| 01.02.12 | AstraZeneca reduce | Nomura | |
| 30.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 23.01.12 | Novartis buy | Nomura | |
| 20.01.12 | Novartis buy | Nomura | |
| 17.01.12 | Novartis buy | Nomura | |
| 13.01.12 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 23.12.11 | Sanofi neutral | Nomura | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
| 09.11.11 | Roche neutral | Nomura | |
| 09.11.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 28.10.11 | AstraZeneca reduce | Nomura | |
| 28.10.11 | Novo Nordisk (spons. ADRs) reduce | Nomura | |
| 27.10.11 | Novartis buy | Nomura | |
| 27.10.11 | Roche neutral | Nomura | |
| 26.10.11 | Sanofi neutral | Nomura | |
| 25.10.11 | Novo Nordisk reduce | Nomura | |
| 25.10.11 | Merck buy | Nomura | |
| 14.10.11 | Grifols buy | Nomura | |
| 06.10.11 | Novartis buy | Nomura | |
| 09.09.11 | Sanofi neutral | Nomura | |
| 22.08.11 | Roche neutral | Nomura | |
| 22.08.11 | Novartis buy | Nomura | |